問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number191622-517-04; VersionNumber:1.0 Current, Effective Date: 29/Dec/2006

2006-06-01 - 2011-12-31

Phase II

Terminated4

  • Trial Applicant

    ALLERGAN PHARMACEUTICALS TAIWAN CO., LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 郭漢崇 Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator YAO-CHI CHUANG Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王炯珵 Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 林登龍 Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    300 participants